Clinical trial
An Open Label Study to Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® (Live Attenuated Rotavirus Vaccine) as a 3-dose Series in Healthy Infants Aged Between 6 Weeks and 8 Weeks in Vietnam
NCT03367559 is registered in ClinicalTrials.gov with Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study to Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® (Live Attenuated Rotavirus Vaccine) as a 3-dose Series in Healthy Infants Aged Between 6 Weeks and 8 Weeks in Vietnam
- Lead sponsor
- Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 8, 2018
- Completion date
- May 31, 2019
- Enrollment
- 360 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.